Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Early sugary diet could mean memory trouble later

Written by | 4 Apr 2021

New research shows how drinking sugary beverages early in life may lead to impaired memory in adulthood. The study, published today in Translational Psychiatry, also is the first to… read more.

Mutations associated with early onset dementia

Written by | 28 Dec 2020

Scientists at Trinity College Dublin announced a significant advance in our understanding of an early onset form of dementia that may also progress our understanding of conditions such… read more.

World’s first major study into MS and pregnancy reveals it delays onset of MS symptoms by more than 3 years

Written by | 6 Oct 2020

A comprehensive international study, led by Monash University researchers, has definitively found that pregnancy can delay the onset of multiple sclerosis (MS) by more than 3 years. MS… read more.

New Mayzent data published in Neurology shows sustained effect in delaying disability for up to five years in secondary progressive multiple sclerosis .- Novartis

Written by | 21 Apr 2020

Novartis announced new Mayzent (siponimod) data in the April supplemental issue of Neurology, the medical journal of the American Academy of Neurology. The data build on existing clinical… read more.

Novartis announces data in Neurology reinforcing the real-world and long-term effectiveness and safety of Aimovig as a preventive treatment across the full spectrum of migraine.

Written by | 16 Apr 2020

Novartis announced that clinical data for Aimovig (erenumab) was reported in Neurology . The data strengthens the role Aimovig as a preventive migraine treatment and confirms its real-world… read more.

Novartis announces data in Neurology reinforcing the real-world and long-term effectiveness and safety of Aimovig as a preventive treatment across the full spectrum of migraine.

Written by | 16 Apr 2020

Novartis announced that clinical data for Aimovig (erenumab) was reported in Neurology . The data strengthens the role Aimovig as a preventive migraine treatment and confirms its real-world… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.